STAAR Surgical
Lake Forest, California, United States · Biotechnology, Health Care, Manufacturing
STAAR Surgical is a leading global developer, manufacturer and marketer of implantable lenses for the eye with a focus on vision correction. The company is committed to providing high-quality products to help patients see better, and has a strong network of surgeons worldwide.
Key facts
- Headquarters
- Lake Forest, California, United States
- Employees
- 756
- Industries
- Biotechnology, Health Care, Manufacturing
- Status
- Public (STAA)
- Website
- staarsurgical.com
- Company page
Recent activity at STAAR Surgical
- : SEC 8-K (5.02): On September 8, 2026, STAAR Surgical Company appointed David Bailey as Chief Commercial Officer, effective the same day. Mr. Bailey previously served as the Company's CEO and President and recently founded a strategic advisory firm. Under the Bailey Agreement, his compensation includes an annual base salary of CHF 462,825 (approximately $575,000) and a target bonus for fiscal 2026 of 60% of his base salary, along with an equity grant valued at $850,000 in the form of RSUs that vest over three years, and a long-term incentive award of $1,400,000. This appointment is significant as it marks the return of a seasoned executive to a key leadership position, likely impacting the Company's strategic direction and operational effectiveness.
- : STAAR Surgical Appoints David Bailey as Chief Commercial Officer
- : SEC 8-K (7.01):
- : SEC 8-K (5.02): On August 4, 2026, STAAR Surgical Company appointed Warren Foust as President and Chief Executive Officer (CEO) and a new member of the Board of Directors, effective immediately. Mr. Foust, who had been serving as Interim Co-CEO since February 2026, previously worked as Worldwide President at Johnson & Johnson Vision, Surgical. In connection with his new role, Mr. Foust's compensation package includes a base salary of $730,000 annually, eligibility for cash bonuses of up to 100% of his salary, and an equity compensation structure that involves time-based stock options and performance-based RSUs. This appointment not only signifies a change in leadership but also emphasizes STAAR's strategic focus on enhancing its executive team to drive future growth.
- : Staar Surgical Appoints Warren Foust as President and Chief Executive Officer
- : SEC 8-K (5.02):
- : STAAR Surgical Appoints Deborah Andrews as Interim Co-Chief Executive Officer and Chief Financial Officer
- : SEC 8-K (5.02): On June 8, 2026, STAAR Surgical Company's Compensation Committee approved an increase in the annual base salary of Deborah Andrews, the Interim Co-Chief Executive Officer and Chief Financial Officer, raising it from $512,000 to $575,000. Additionally, her target annual cash bonus was increased from 55% to 60% of her base salary. These adjustments are effective as of June 8, 2026, and were made following a review of competitive market compensation data, reflecting recognition of Ms. Andrews' valuable contributions to the Company's strategic and operational goals.
- : SEC 8-K (7.01): On May 13, 2026, STAAR Surgical Company held a conference call and webcast at 5:30 p.m. Eastern time to discuss the company's results for the quarter ended on the same date. The call featured the Company's Interim Co-Chief Executive Officer, President and Chief Operating Officer, as well as the Interim Co-Chief Executive Officer and Chief Financial Officer. This event is part of their regular disclosure obligations under Regulation FD, designed to ensure that all investors have equal access to important information. The provided details include a press release dated May 13, 2026, which outlines their quarterly performance and related financial metrics.
- : SEC 8-K (7.01): On April 8, 2026, STAAR Surgical Company issued a press release detailing selected preliminary financial results for the first quarter ended April 3, 2026. This disclosure is part of their Regulation FD requirements, which aims to ensure that all investors have equal access to the company's financial information. The Company plans to release its full first quarter financial results in early May 2026. This preliminary information might impact investor expectations and stock performance as it provides early insights into the company's financial health.
Leadership
- David Bailey, Chief Commercial Officer
- Deborah Andrews, Executive Vice President
- Warren Foust, President
- Nathaniel Sisitsky, General Counsel
- Nancy Sabin, Chief Marketing Officer
Verified email and direct lines for STAAR Surgical’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
STAAR Surgical files 7 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
STAAR Surgical in the news
Companies similar to STAAR Surgical
- Epredia · Biotechnology, Health Care, Manufacturing, Medical Device
- Inogen · Biotechnology, Health Care, Manufacturing, Medical Device
- Haag-Streit · Biotechnology, Health Care, Manufacturing, Medical Device
- Accurate Medical Therapeutics Ltd · Biotechnology, Health Care, Manufacturing, Medical Device
- TransMedics Group · Biotechnology, Health Care, Manufacturing, Medical Device
About STAAR Surgical: questions and answers
What does STAAR Surgical do?
STAAR Surgical is a leading global developer, manufacturer and marketer of implantable lenses for the eye with a focus on vision correction. The company is committed to providing high-quality products to help patients see better, and has a strong network of surgeons worldwide.
Where is STAAR Surgical headquartered?
STAAR Surgical is headquartered in Lake Forest, California, United States.
How many employees does STAAR Surgical have?
STAAR Surgical has about 756 employees.
Who leads STAAR Surgical?
Deborah Andrews is an Executive Vice President at STAAR Surgical.
What is the latest news on STAAR Surgical?
On Sep 10, 2026, SEC 8-K (5.02): On September 8, 2026, STAAR Surgical Company appointed David Bailey as Chief Commercial Officer, effective the same day. Mr. Bailey previously served as the Company's CEO and President and recently founded a strategic advisory firm. Under the Bailey Agreement, his compensation includ
Is STAAR Surgical a public company?
Yes. STAAR Surgical is publicly traded under the ticker STAA.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy